Please note that the copy function is not enabled for this field.
If you wish to
modify
existing outcomes, please copy and paste the current outcome text into the Update field.
LOGIN
CREATE ACCOUNT
LOGIN
CREATE ACCOUNT
MY TRIALS
REGISTER TRIAL
FAQs
HINTS AND TIPS
DEFINITIONS
Trial Review
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this
information for consumers
Download to PDF
Trial registered on ANZCTR
Registration number
ACTRN12617001558314
Ethics application status
Approved
Date submitted
1/11/2017
Date registered
15/11/2017
Date last updated
17/07/2018
Type of registration
Prospectively registered
Titles & IDs
Public title
Effect of warm humidified insufflated carbon dioxide on wound bacterial load in open elective gastrointestinal surgery: a pilot investigation.
Query!
Scientific title
Effect of warm humidified insufflated carbon dioxide on wound bacterial load in open elective gastrointestinal surgery: a pilot investigation.
Query!
Secondary ID [1]
293247
0
None
Query!
Universal Trial Number (UTN)
U1111-1137-6070
Query!
Trial acronym
Query!
Linked study record
Query!
Health condition
Health condition(s) or problem(s) studied:
gastrointestinal surgery
305295
0
Query!
Condition category
Condition code
Surgery
304600
304600
0
0
Query!
Other surgery
Query!
Oral and Gastrointestinal
304601
304601
0
0
Query!
Other diseases of the mouth, teeth, oesophagus, digestive system including liver and colon
Query!
Infection
304602
304602
0
0
Query!
Studies of infection and infectious agents
Query!
Intervention/exposure
Study type
Interventional
Query!
Description of intervention(s) / exposure
Patients will be randomly allocated to receive CO2 insufflation during their surgical procedure or standard care (Surgery without any additional intervention). The CO2 will be delivered into the open peritoneal cavity by the Fisher and Pykel HumigardTM surgical humidification system throughout the duration of the surgery (from incision to surgical close).
The HumigardTM surgical humidification system creates a local atmosphere of CO2 heated to 37oC at 100% relative humidity which is thought to decrease airborne contamination, reduce bacterial growth and decreased heat loss during surgery.
Intervention arm - Consented patients undergoing Whipples procedure at Auckland City Hospital will receive insufflated CO2 in the surgical wound throughout the procedure. The Humigard TM device will be set up and operated by the consultant surgeon and the surgical team in the operating theatre. Swabs will be taken at time of incision, 1 hour, 2 hours and at surgical wound close. These swabs will be analysed for bacterial growth and compared against the patients how did not receive CO2. At time of incision and closure, 2 6mm skin biopsies will be taken along the incision line. This is to determine wound edge tissue response. A research nurse will be present throughout the procedure and will assist in sample collection and Humigard maintenance.
All patients will be followed by a research nurse at 30 days over the phone to assess if there has been any surgical site infection.
Query!
Intervention code [1]
299510
0
Treatment: Devices
Query!
Intervention code [2]
299511
0
Prevention
Query!
Comparator / control treatment
Control arm
All procedures will be carried out as described in the intervention arm but without the use of the Humigard device during surgery. This is the active control group and patients will receive standard of care with additional swabs and a 30 day follow up phone call.
Query!
Control group
Active
Query!
Outcomes
Primary outcome [1]
303832
0
To quantify the number of bacteria present in the open surgical wound as determined by taking swabs for qPCR.
Query!
Assessment method [1]
303832
0
Query!
Timepoint [1]
303832
0
qPCR swabs are taken after incision but before retraction, 1 hour into surgery, 2 hours into surgery and before closure and before retractors are removed.
A qPCR swab is also taken when the surgical dressing is removed at 5 days post-surgery. If evidence of SSI is present at day 5, discharge or 30 days post surgery then the qPCR swab taken at day 5 post-surgery will be sent for analysis.
Query!
Secondary outcome [1]
340248
0
Bacterial load as determined by taking swabs during surgery for culture of wound specimens (colony forming units).
Query!
Assessment method [1]
340248
0
Query!
Timepoint [1]
340248
0
Bacterial culture swabs are taken after incision but before retraction, 1 hour into surgery, 2 hours into surgery and before closure and before retractors are removed.
Query!
Secondary outcome [2]
340249
0
Wound edge tissue response as determined by analysis of 6mm tissue biopsies. These are taken at time of main abdominal incision and after 2 hours of surgery. Each biopsy will be either immediately fixed or frozen for tissue analysis. Analysis may include: gene expression arrays, immunohistochemistry, histology, protein profiles, metabolite and lipid profiles, cytokine and other appropriate laboratory investigations to measure the response of the skin edge to different gaseous environments.
Query!
Assessment method [2]
340249
0
Query!
Timepoint [2]
340249
0
2 x 6mm tissue biopsies will be taken at time of main abdominal incision and after 2 hours of surgery (4 in total).
Query!
Eligibility
Key inclusion criteria
1. Scheduled to undergo upper gastrointestinal surgical procedures longer than 120 minutes involving an open midline laparotomy incision.
2. Able to give informed consent
3. Male or female between 18 and 65 years of age
4. HbA1c less than 49 mmol/mol
Query!
Minimum age
18
Years
Query!
Query!
Maximum age
65
Years
Query!
Query!
Sex
Both males and females
Query!
Can healthy volunteers participate?
No
Query!
Key exclusion criteria
1. Evidence, preoperatively, of any of the following: sepsis, severe sepsis, or septic shock
2. BMI over 30
3. Currently abdominal wall infection/surgical site infection secondary to previous laparotomy/laparoscopy or form any other cause
4. History of laparotomy within the last 60 days
5. Immunological disease (e.g. HIV/AIDS)
6. Systemic steroid use or other immunosuppressant medication
7. ASA score over and including 4
8. Uncontrolled diabetes mellitus
9. Current smoker or not willing to stop smoking 30 days prior to surgery
10. Wound protector use for the surgery
Query!
Study design
Purpose of the study
Prevention
Query!
Allocation to intervention
Randomised controlled trial
Query!
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
Sealed opaque envelopes
Query!
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
Simple randomisation using a randomisation table created by computer software (i.e. computerised sequence generation).
Query!
Masking / blinding
Blinded (masking used)
Query!
Who is / are masked / blinded?
The people receiving the treatment/s
Query!
Query!
Query!
Query!
Intervention assignment
Parallel
Query!
Other design features
Query!
Phase
Not Applicable
Query!
Type of endpoint/s
Efficacy
Query!
Statistical methods / analysis
As the study is a pilot study a total of 10 patients will be enrolled in the study (5 per treatment group).
Query!
Recruitment
Recruitment status
Recruiting
Query!
Date of first participant enrolment
Anticipated
20/11/2017
Query!
Actual
25/01/2018
Query!
Date of last participant enrolment
Anticipated
31/12/2018
Query!
Actual
Query!
Date of last data collection
Anticipated
28/02/2019
Query!
Actual
Query!
Sample size
Target
10
Query!
Accrual to date
3
Query!
Final
Query!
Recruitment outside Australia
Country [1]
9331
0
New Zealand
Query!
State/province [1]
9331
0
Auckland
Query!
Funding & Sponsors
Funding source category [1]
297876
0
Commercial sector/Industry
Query!
Name [1]
297876
0
Fisher and Paykel Healthcare
Query!
Address [1]
297876
0
15 Maurice Paykel Place
East Tamaki
Auckland 2013
Query!
Country [1]
297876
0
New Zealand
Query!
Primary sponsor type
Commercial sector/Industry
Query!
Name
Fisher and Paykel Healthcare
Query!
Address
15 Maurice Paykel Place
East Tamaki
Auckland 2013
Query!
Country
New Zealand
Query!
Secondary sponsor category [1]
296931
0
University
Query!
Name [1]
296931
0
University of Auckland
Query!
Address [1]
296931
0
12th Floor, Support Building, Auckland City Hospital
Park Road,
Grafton
Auckland
1010
Query!
Country [1]
296931
0
New Zealand
Query!
Ethics approval
Ethics application status
Approved
Query!
Ethics committee name [1]
298926
0
Northern A Health and Disability Ethics Committee
Query!
Ethics committee address [1]
298926
0
Health and Disability Ethics Committees
Ministry of Health
Freyberg Building
20 Aitken Street
PO Box 5013
Wellington
6011
Query!
Ethics committee country [1]
298926
0
New Zealand
Query!
Date submitted for ethics approval [1]
298926
0
22/05/2015
Query!
Approval date [1]
298926
0
15/07/2015
Query!
Ethics approval number [1]
298926
0
15/NTA/66
Query!
Summary
Brief summary
Surgical site infection (SSI) is an infection which can develop in the wound created by a surgical procedure. SSI is a potential side effect of any surgical procedure. The purpose of this investigation is to provide data for helping design a larger controlled study which will investigate whether blowing warm, humidified carbon dioxide (CO2) into the surgical cavity during surgery can reduce the number of bacteria in the surgical wound, potentially reducing the risk of SSI. We are also interested in how the gas treatment alters the way your skin wound edge responds and heals. It is possible that the gas may improve the healing process after surgery.
Participants undergoing elective gastrointestinal surgery at Auckland City Hospital who meet the inclusion and exclusion criteria will be offered the opportunity to participate in the pilot study.
If patients meet the above criteria and choose to take part in the study, they will be randomised (selected by chance by a computer) to receive the CO2 treatment or standard care (no CO2). If randomised into the CO2 treatment group, warm humidified CO2 gas will be slowly insufflated (blown) into the abdominal cavity during the planned surgery. The CO2 gas is delivered by a small, flexible, non-invasive tube which is placed inside the surgical wound during the operation.
This trial will take 30 days to complete, not including an initial assessment to check if the patient meets the inclusion and exclusion criteria. There will be 4 scheduled assessments. These assessments will be undertaken during the standard routine check-up expected after surgery so will not take any additional time. Assessments will be made at the following time points. Day 1 (surgery), Day 5 (in-patient), Discharge, Day 30 Follow-Up Visit.
To measure the number of bacteria in the wound, a swab will be taken by gently wiping the edge of the wound of all participants. Samples will be taken by the surgeon while the patient is under an anesthesia at the beginning of the surgery; 1 hour into the procedure; 2 hours into the procedure; and at the end of the surgery before the surgical wound is closed.
In addition two sets of two small biopsies (small samples of your skin wound) during the operation will be taken. These biopsies are taken while the patient is under anesthesia from along the skin edges that are already part of the main operation wound. They will be inside the area of the main operation wound and will not make the scar any longer.
On Day 5, the surgical dressing will be removed at 48hrs post-surgery, and the wound will be reviewed by a nurse to check for any potential SSI.
At discharge the surgical wound will be reviewed by a nurse to check for any potential SSI.
The patient will be contacted again at 30 days to discuss any SSI have developed.
Query!
Trial website
Query!
Trial related presentations / publications
Query!
Public notes
Query!
Contacts
Principal investigator
Name
78674
0
Prof John Windsor
Query!
Address
78674
0
12th Floor, Support Building, Auckland City Hospital,
Park Road, Grafton,
Auckland
1010
Query!
Country
78674
0
New Zealand
Query!
Phone
78674
0
+6493737599
Query!
Fax
78674
0
+6493779656
Query!
Email
78674
0
[email protected]
Query!
Contact person for public queries
Name
78675
0
Ms Jennifer Mackie
Query!
Address
78675
0
12th Floor, Support Building, Auckland City Hospital,
Park Road, Grafton,
Auckland
1010
Query!
Country
78675
0
New Zealand
Query!
Phone
78675
0
+64212751203
Query!
Fax
78675
0
Query!
Email
78675
0
[email protected]
Query!
Contact person for scientific queries
Name
78676
0
Prof John Windsor
Query!
Address
78676
0
12th Floor, Support Building, Auckland City Hospital,
Park Road, Grafton,
Auckland
1010
Query!
Country
78676
0
New Zealand
Query!
Phone
78676
0
+6493737599
Query!
Fax
78676
0
+6493779656
Query!
Email
78676
0
[email protected]
Query!
No information has been provided regarding IPD availability
What supporting documents are/will be available?
No Supporting Document Provided
Current supporting documents:
Updated to:
Doc. No.
Type
Citation
Link
Email
Other Details
Attachment
23571
Clinical study report
Results publications and other study-related documents
Documents added manually
No documents have been uploaded by study researchers.
Documents added automatically
No additional documents have been identified.
Download to PDF